title: PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis.
abstract: We found that in MCF-7 breast carcinoma cells, PI3K and Akt suppressed a dose-dependent induction of apoptosis by tumor necrosis factor alpha (TNF). PI3K and Akt stimulated NF-kappaB activation in a dose-dependent manner, suggesting a common link between these two pathways. TNF has been shown to activate both an apoptotic cascade, as well as a cell survival signal through NF-kappaB. PI3K and AKT cell survival signaling were correlated with increased TNF-stimulated NF-kappaB activity in MCF-7 cells. We demonstrate that while both TNFR1 and NIK are partially involved in Akt-induced NF-kappaB stimulation, a dominant negative IkappaBalpha completely blocked Akt-NF-kappaB cross-talk. PI3K-Akt signaling activated NF-kappaB through both TNFR signaling-dependent and -independent mechanisms, potentially representing a mechanism by which Akt functions to suppress apoptosis in cancer.
authors.affiliation: Tulane-Xavier Center for Bioenvironmental Research, Department of Pharmacology, Tulane University Medical Center, New Orleans, LA 70112, USA. mburow@tcs.tulane.edu
authors.forename: M E
authors.initials: ME
authors.lastname: Burow
authors.forename: C B
authors.initials: CB
authors.lastname: Weldon
authors.forename: L I
authors.initials: LI
authors.lastname: Melnik
authors.forename: B N
authors.initials: BN
authors.lastname: Duong
authors.forename: B M
authors.initials: BM
authors.lastname: Collins-Burow
authors.forename: B S
authors.initials: BS
authors.lastname: Beckman
authors.forename: J A
authors.initials: JA
authors.lastname: McLachlan
mesh_terms: D017209:Apoptosis; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008156:Luciferases / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D010957:Plasmids / Q000378:metabolism; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D011518:Proto-Oncogene Proteins; D051057:Proto-Oncogene Proteins c-akt; D011994:Recombinant Proteins / Q000378:metabolism; D015398:Signal Transduction; D014162:Transfection; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
chemical_list: D008156:Luciferases; D016328:NF-kappa B; D019869:Phosphatidylinositol 3-Kinases; D017346:Protein Serine-Threonine Kinases; D011518:Proto-Oncogene Proteins; D051057:Proto-Oncogene Proteins c-akt; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; C494918:AKT1 protein, human